- DuPont is transforming its Athlone facility to meet global MABR demand.
- The project includes staff training and is supported by IDA Ireland.
- OxyMem's MABR technology is key for secondary wastewater treatment.
- The investment aims to enhance production technology and product design.
Investment Overview
DuPont Water Solutions is investing millions to transform its OxyMem™ Membrane Aerated Biofilm Reactor (MABR) manufacturing facility in Athlone, Ireland. This investment aims to meet the growing global demand for MABR technology.
Technological Advancements
OxyMem™ was the first to commercialize MABR technology, which is crucial for secondary wastewater treatment. The investment will enhance production technology, improve product design, and increase efficiency and reliability.
Support and Training
The project includes additional training for staff at the Athlone site and is supported by the Irish Government through IDA Ireland. This initiative will help upskill employees and support regional enterprise development.
Strategic Importance
Denis Curran from IDA Ireland highlighted that this investment aligns with their strategy of attracting investments to regional locations. It positions OxyMem for future growth opportunities and strengthens its local footprint in R&D and headcount.
